Chris Elliot, manager of the IFSL Evenlode Global Equity fund, believes there are sound fundamentals behind the recent rotation. He points out that his portfolio has now delivered organic revenue growth of 7-9% for 16 quarters in a row, and 17 of the 19 companies that reported this quarter beat profit forecasts this season.
Quality strikes back as tech stumbles
By James Yardley on 18 November 2026 in Equities
Jensen Huang’s complicated love life is the latest chink in the armour of the AI trade. A lacklustre funding round for OpenAI, CoreWeave’s debt problems and the election victory of AI-sceptic Democrats have clouded the outlook for investors’ formerly favourite sector. Performance has been lacklustre since the start of the year, as investors have hunted out alternatives.

In particular, investors have returned to higher-quality companies as a refuge from increasingly turbulent technology stocks. Over six months, technology is bottom of the table for sector performance, with companies down an average of 1.4%*. At the top are traditional quality sectors such as healthcare (29.4%), consumer non-cyclicals (12.4%) and financials (8.8%)**.
This has also shifted the type of active managers that have done well. It has been a good period for the Mid Wynd International Investment Trust, for example, which is around 6% ahead of its benchmark over the last quarter***. The IFSL Evenlode Global Equity portfolio was 11.2% ahead of its benchmark, the MSCI World Index, in October alone. Evenlode says it was the best month for the quality factor since 1957***.
It has been a long time coming. Owning profitable, cash-generative, lightly indebted companies has been deeply unfashionable at a time when investors have been laser-focused on the AI trade. Valuations had dropped to historic lows in sectors such as healthcare and some consumer-focused areas. Whereas quality companies used to trade at a premium to the rest of the market because investors were willing to pay up for reliability, that premium has been eroded.
A brightening picture
But can it last? Or is it a temporary reaction to the weakness of the AI trade?

While the technology sector has still reported strong quarterly earnings as a whole, three of the mega-caps – Alphabet, Amazon.com, and Meta Platforms – were behind expectations. According to Factset data, only 5.5% of technology companies reported earnings ahead of expectations, that compared to 13.7% for healthcare and 10.5% for utilities****. Earnings momentum is broadening.
There have also been specific reasons for improvements in certain sectors. The healthcare sector, for example, has benefited from renewed merger and acquisition activity, scientific breakthroughs such as cancer vaccines and a strong second quarter earnings season. Low valuations provided a strong foundation for growth.
Consumer sectors had also been due a rebound after a weak period of performance. There remain some headwinds for consumer stocks, as interest rate rises and inflationary pressures weigh on household budgets. However, earnings growth has been improving. Evenlode says: “Results for the fast-moving consumer goods companies have been in the mid-single digits, with P&G’s +4% a marked improvement on the stalled top line of late. Unilever (+5%) and Nestlé (+4%) both reported a balance of price and volume contributing to growth.” At the same time, valuations had dipped to multi-year lows.
The right time
It is also intuitive that investors should turn to more defensive areas as crowded growth trends falter and investors are less willing to pay a high price for hope. Cristophe Nagy, co-manager of the Comgest Growth America fund, says: “Our focus on earnings quality may weigh on relative performance during a cyclical boom, when low-margin, cyclical, or leveraged companies tend to outperform. We believe, however, that the portfolio should prove resilient in downturns.” This has been the case.

He also highlights the ongoing valuation argument for quality growth companies: “Despite unchanged fundamentals, the portfolio’s valuation premium relative to the S&P 500 is well below its long-term average. In our view, this makes its quality growth characteristics attractively valued relative to their own history.”
While there are sound reasons for the revival in quality growth companies, it is still true that its recent strength is at least partially premised on the weakness of the technology sector. The fundamentals may be sound, but investors need to be willing to look beyond technology to recognise this strength. With this in mind, if the AI trade continues to wobble, quality growth looks like it might provide a safe haven, but if it revives, investors may have their heads turned once again.
Our recent interview with Mark Ellis, manager of the Nutshell Growth fund, explores a more active approach to quality growth investing, in the latest instalment of the Investing on the go podcast.
*Source: FE Analytics, total returns in pounds sterling, 13 November 2026
**Source: Reuters, US sectors & industries, as of 16 November 2026
***Source: fund factsheet, 31 October 2026
****Source: Factset, 13 November 2026
This article is provided for information only. The views of the author and any people quoted are their own and do not constitute financial advice. The content is not intended to be a personal recommendation to buy or sell any fund or trust, or to adopt a particular investment strategy. However, the knowledge that professional analysts have analysed a fund or trust in depth before assigning them a rating can be a valuable additional filter for anyone looking to make their own decisions.
Past performance is not a reliable guide to future returns. Market and exchange-rate movements may cause the value of investments to go down as well as up. Yields will fluctuate and so income from investments is variable and not guaranteed. You may not get back the amount originally invested. Tax treatment depends of your individual circumstances and may be subject to change in the future. If you are unsure about the suitability of any investment you should seek professional advice.
Whilst FundCalibre provides product information, guidance and fund research we cannot know which of these products or funds, if any, are suitable for your particular circumstances and must leave that judgement to you. Before you make any investment decision, make sure you’re comfortable and fully understand the risks. Further information can be found on Elite Rated funds by simply clicking on the name highlighted in the article.
Related insights

The Junior ISA: A gift anyone can give

Healthcare is back: what’s driving the sector’s revival?

412. Buying a Bentley for the price of a Mondeo
